BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Our medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement.
Our BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates the time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets.
At BrightInsight, our vision is to transform patient outcomes globally by bringing the power of digital technology to healthcare.
Our mission is to accelerate regulated digital health innovation for our biopharma and medtech customers through our scalable medical-grade platform.
Whether you’re connecting a medical device or combination product, developing a companion app or deploying a smart algorithm, we make digital transformation easy while accelerating your time to market, minimizing your risk and future-proofing your digital health offerings.
Location: United States, California, San Jose
Employees: 51-200
Total raised: $166M
Founded date: 2017
Investors 7
Funding Rounds 3
Date | Series | Amount | Investors |
30.03.2021 | Series C | $101M | General Ca... |
23.06.2020 | Series B | $40M | - |
05.09.2019 | Series A | $25M | - |
Mentions in press and media 31
Date | Title | Description | Source |
07.02.2023 | Digital Health Predictions: Uncertainty Will Trigger Innovat... | Kal Patel, MD, is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, ... | forbes.com... |
21.11.2022 | Digital health news, funding round up in the prior week; Nov... | DispatchHealth raised $330M; Sondermind bought True Brain; Elizabeth Holmes gets 11 years in prison ... | vator.tv/n... |
27.09.2022 | BrightInsight brings Woebot Health, Xealth, and Claritas Rx ... | The company also announced it joined General Catalyst’s Health Assurance network Earlier this month... | vator.tv/n... |
13.06.2022 | BrightInsight Launches Digital Disease Management Solution f... | What You Should Know: – BrightInsight, Inc., provider of the leading global platform for biopharma ... | hitconsult... |
18.02.2022 | The Importance Of Engaging Clinicians In Digital Health | Kal Patel, MD, is CEO and Co-Founder of BrightInsight. He has over 20 years of experience in pharma,... | forbes.com... |
17.12.2021 | Where SaMD And Digital Therapeutics Are Headed In 2022 And B... | Kal Patel, MD, is CEO and Co-Founder of BrightInsight. He has over 20 years of experience in pharma,... | forbes.com... |
05.05.2021 | Strengthening Corporate Long-Term Value Through Advisory Boa... | Kal Patel, MD, is CEO and Co-Founder of BrightInsight. He has over 20 years of experience in pharma,... | forbes.com... |
29.04.2021 | Eclipse Ventures has $500 million more to digitize old-line ... | Two years ago, we talked with Lior Susan, the founder of now six-year-old Eclipse Ventures in Palo A... | techcrunch... |
30.03.2021 | General Catalyst leads $101M investment in startup helping p... | The startup was spun out of contract manufacturer Flex in 2017 by Dr. Kal Patel, the former chief co... | medcitynew... |
30.03.2021 | BrightInsight, a platform for digitizing the medtech and pha... | The company also added Dan Goldsmith, CEO of Tendo Systems, to its board Over the last year, COVID ... | vator.tv/n... |
Show more